CURE Pharmaceutical, an innovative drug delivery and development company, today named Dr. Vered Gigi, Vice President of Strategy and Business Development. Dr. Gigi will oversee CURE’s strategy to deliver sustained growth and diversified revenue.
“The CURE team and the technology offer a clear path to a better and much needed patient experience with medications,” said Dr. Vered Gigi. “I am thrilled to be a part of this group to improve the efficacy and safety of new and existing drugs.”
Read full articles:
CURE Pharmaceutical Adds New VP of Strategy and Business Development (Healthcare Dive)
CURE Pharmaceutical Adds New VP of Strategy and Business Development (FirstWord Pharma)
